Likewise, a synthetic MUC1 glycopeptide linked to a B-cell and a T-cell epitope together with poly I:C as an adjuvant elicited significant IgG titers against tumor-associated MUC1 expressed in breast cancer cells [82]. Here, MUC1 is linked to breast carcinoma.